New Study Shows Flavors to Blame in Nation’s Youth E-Cigarette Epidemic
WASHINGTON, D.C.—According to a study released today by the Centers for Disease Control and Prevention and the U.S.
WASHINGTON, D.C.—According to a study released today by the Centers for Disease Control and Prevention and the U.S.
Cerca de 700 defensores del cáncer, incluidos pacientes, sobrevivientes y sus seres queridos, de los 50 estados y territorios y casi todos los distritos congresuales harán llamadas y accederán a reuniones virtuales esta semana para pedir a los miembros del Congreso que hagan de la lucha contra el cáncer una prioridad nacional.
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) lanzó una nueva campaña publicitaria esta semana destacando su firme apoyo a la Ley de Cobertura de Medicaid de las Pruebas de Detección Temprana de Múltiples Cánceres (H.R. 1946/S. 1873), la legislación que tiene como objetivo mejorar el acceso a exámenes de detección de cáncer nuevos e innovadores entre los beneficiarios de Medicare
The House Ways and Means Committee is expected to vote today on legislation that if enacted would greatly improve public health.
Washington, D.C.—The House Energy and Commerce Committee will vote today on legislation that would greatly improve the availability and affordability of health care for millions of Americans.
More than a dozen patient advocacy organizations are commending the House Ways and Means Committee as it begins considering details of legislation to create the country’s first ever national paid family and medical leave program as part of the budget reconciliation package.
Washington, D.C. — Enviamos nuestros mejores deseos a la senadora Amy Klobuchar, demócrata de Minnesota, mientras comparte su experiencia personal con el cáncer de mama en etapa inicial. Las declaraciones recientes de la senadora Klobuchar sobre la importancia de las pruebas de detección de rutina y el seguimiento son recordatorios de que la detección temprana del cáncer puede brindar la mejor oportunidad para un tratamiento exitoso.
Washington, D.C.—Today the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other tobacco product manufacturers’ applications to keep their harmful products on the market.
The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Departments of Health and Human Services, Labor and Treasury to put cancer patients and survivors first when implementing rules around surprise medical bills.
The U.S. Food and Drug Administration issued marketing denial orders (MDOs) to 31 companies who sought to sell 300,000 flavored electronic cigarettes. The decision requires these manufacturers to remove those identified products already on the market.